ALKEM Alkem Laboratories Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: HealthcareLive setups screens ALKEM is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about ALKEM
In the last completed session, Alkem Laboratories Ltd. closed +2.01% with futures open interest moving +1.5%. That combination — price rising while OI builds — is classified as a Long Buildup, meaning derivative traders are adding fresh bullish positions into strength rather than merely covering existing shorts. The stock's option PCR sits at 0.41, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹5,600 sits 1.4% below the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Alkem Laboratories Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Alkem Laboratories Ltd. suggests upside momentum is building.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Insider & Promoter Filings last 60 days
Option Chain Ladder nearest expiry 2026-07-28 · spot 5,654 · EOD 2026-07-20
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
| 5350 | ||
|
IV 41%
Δ 0.80
θ -7.1
ν 2
|
5400 | |
|
IV 37%
Δ 0.78
θ -7.0
ν 2
|
5450 |
IV 27%
Δ -0.15
θ -3.4
ν 2
|
|
IV 34%
Δ 0.74
θ -6.8
ν 3
|
5500 S |
IV 27%
Δ -0.21
θ -4.1
ν 2
|
|
IV 32%
Δ 0.68
θ -7.0
ν 3
|
5550 |
IV 26%
Δ -0.28
θ -4.5
ν 3
|
|
IV 30%
Δ 0.61
θ -7.0
ν 3
|
5600 MP |
IV 25%
Δ -0.37
θ -4.9
ν 3
|
|
IV 30%
Δ 0.53
θ -7.2
ν 3
|
5650 |
IV 25%
Δ -0.47
θ -5.0
ν 3
|
|
IV 29%
Δ 0.44
θ -6.9
ν 3
|
5700 |
IV 24%
Δ -0.58
θ -4.7
ν 3
|
|
IV 29%
Δ 0.36
θ -6.4
ν 3
|
5750 |
IV 22%
Δ -0.69
θ -3.6
ν 3
|
|
IV 29%
Δ 0.28
θ -5.8
ν 3
|
5800 |
IV 21%
Δ -0.80
θ -2.5
ν 2
|
|
IV 30%
Δ 0.22
θ -5.2
ν 2
|
5850 |
IV 132%
Δ -0.54
θ -28.7
ν 3
|
|
IV 30%
Δ 0.17
θ -4.5
ν 2
|
5900 |
IV 136%
Δ -0.55
θ -29.4
ν 3
|
|
IV 31%
Δ 0.13
θ -3.8
ν 2
|
5950 |
IV 136%
Δ -0.57
θ -29.3
ν 3
|
Chain Interpretation
Strategy Builder multi-leg payoff for ALKEM options · 2026-07-28 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
ALKEM — frequently asked questions
What is the Alkem Laboratories Ltd. share price today?
ALKEM is trading at ₹5,681.50 (+0.50% vs previous close), per the latest update on this page.
What is the P/E ratio of Alkem Laboratories Ltd.?
ALKEM (Alkem Laboratories Ltd.) has a trailing twelve-month P/E ratio of 29.5.
What is the market cap of Alkem Laboratories Ltd.?
ALKEM has a market capitalisation of approximately ₹67,931 crore.
What is the ROE of Alkem Laboratories Ltd.?
ALKEM has a return on equity (ROE) of about 17.6%.
Is ALKEM near its 52-week high?
ALKEM is trading -4.7% from its 52-week high of ₹5,933.50 as of 2026-07-20.
What is the RSI of ALKEM?
The 14-day RSI of ALKEM is 57.7, which is considered neutral.
Is ALKEM above its 200-day moving average?
ALKEM is trading above its 200-DMA of ₹5,533.55 (+2.2% away).
What is the F&O buildup in ALKEM?
The latest end-of-day derivatives data classifies ALKEM as Long Buildup (bias: bullish), based on the day's combined price and open-interest change.
What is the max pain and PCR for ALKEM options?
ALKEM's option-chain max pain strike is ₹5,600 and its put-call ratio (OI) is 0.41, from the latest end-of-day option chain.
Are FIIs or big investors buying ALKEM?
Strota tracks every bulk and block deal in ALKEM with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.